August 8, 2018
WASHINGTON, D.C. – Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued this statement following the announcement from the Centers for Medicare & Medicaid Services (CMS) on changes to prescription drug policies for Medicare Part B-covered drugs in Medicare Advantage plans:
“Patients and families deserve the prescription drugs they need at a price they can afford. The new CMS policy helps deliver on that promise while also helping to ensure patients continue to have access to safe, effective, and evidence-based care.
“We commend CMS for their leadership to strengthen the private sector’s ability to implement market-based solutions that can lower the cost of high-priced drugs for consumers. This approach empowers Medicare Advantage plans to negotiate lower drug prices – so that health insurance providers can reduce costs for patients and hardworking taxpayers. We look forward to working with CMS and the Administration on these changes, and are strongly committed to protecting patients and bringing down the price of medications for every American.”